Medacta Group (OTCMKTS:MEDGF – Get Free Report) and Vivos Therapeutics (NASDAQ:VVOS – Get Free Report) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, profitability, valuation, risk, dividends and earnings.
Valuation and Earnings
This table compares Medacta Group and Vivos Therapeutics’ revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|Vivos Therapeutics||$16.02 million||0.49||-$23.84 million||($0.71)||-0.37|
Medacta Group has higher earnings, but lower revenue than Vivos Therapeutics.
|Net Margins||Return on Equity||Return on Assets|
This is a summary of current recommendations for Medacta Group and Vivos Therapeutics, as provided by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
Institutional & Insider Ownership
15.7% of Vivos Therapeutics shares are owned by institutional investors. 9.6% of Vivos Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
Vivos Therapeutics beats Medacta Group on 5 of the 8 factors compared between the two stocks.
About Medacta Group
Medacta Group SA develops, manufactures, and distributes orthopedic and neurosurgical medical devices Europe, North America, the Asia-Pacific, and internationally. It offers personalized 3D planning tools for use in hip, knee, shoulder, sports medicine, and spine procedures. The company was founded in 1958 and is headquartered in Castel San Pietro, Switzerland.
About Vivos Therapeutics
Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment alternatives for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. The company also offers VivoScore Program, a screening and home sleep test in adults and children. It markets and sells its appliances, and related treatments and services to licensed professionals, primarily general dentists in the United States and Canada. The company was founded in 2016 and is based in Littleton, Colorado.
Receive News & Ratings for Medacta Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medacta Group and related companies with MarketBeat.com's FREE daily email newsletter.